Literature DB >> 21666123

Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension.

Scott C Supowit1, Khurshed A Katki, Travis W Hein, Prakash Gupta, Lih Kuo, Ian M Dickerson, Donald J Dipette.   

Abstract

In subtotal nephrectomy (SN)- and salt-induced hypertension, calcitonin gene-related peptide (CGRP) plays a compensatory role to attenuate the blood pressure increase in the absence of an increase in the neuronal synthesis and release of this peptide. Therefore, the purpose of this study was to determine whether the mechanism of this antihypertensive activity is through enhanced sensitivity of the vasculature to the dilator actions of this neuropeptide. Hypertension was induced in Sprague-Dawley rats by SN and 1% saline drinking water. Control rats were sham-operated and given tap water to drink. After 11 days, rats had intravenous (drug administration) and arterial (continuous mean arterial pressure recording) catheters surgically placed and were studied in a conscious unrestrained state. Baseline mean arterial pressure was higher in the SN-salt rats (157 ± 5 mmHg) compared with controls (128 ± 3 mmHg). Administration of CGRP (and adrenomedullin) produced a significantly greater dose-dependent decrease in mean arterial pressure in SN-salt rats compared with controls (∼2.0-fold for both the low and high doses). Interestingly, isolated superior mesenteric arterioles from SN-salt rats were significantly more responsive to the dilator effects of CGRP (but not adenomedullin) than the controls (pEC(50), SN-salt, 14.0 ± 0.1 vs. control, 12.0 ± 0.1). Analysis of the CGRP receptor proteins showed that only the receptor component protein was increased significantly in arterioles from SN-salt rats. These data indicate that the compensatory antihypertensive effects of CGRP result from an increased sensitivity of the vasculature to dilator activity of this peptide. The mechanism may be via the upregulation of receptor component protein, thereby providing a more efficient coupling of the receptor to the signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666123      PMCID: PMC3191084          DOI: 10.1152/ajpheart.00598.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

Review 1.  International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.

Authors:  David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 2.  RAMPs: accessory proteins for seven transmembrane domain receptors.

Authors:  S M Foord; F H Marshall
Journal:  Trends Pharmacol Sci       Date:  1999-05       Impact factor: 14.819

3.  Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries.

Authors:  Philip Hasbak; Karen Eskesen; Søren Schifter; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 4.  Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials.

Authors:  S J Wimalawansa
Journal:  Endocr Rev       Date:  1996-10       Impact factor: 19.871

5.  Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide.

Authors:  D J DiPette; K Schwarzenberger; N Kerr; O B Holland
Journal:  Am J Med Sci       Date:  1989-02       Impact factor: 2.378

6.  Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension.

Authors:  Scott C Supowit; Khurshed A Katki; Travis W Hein; Prakash Gupta; Lih Kuo; Ian M Dickerson; Donald J Dipette
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

7.  Regional hemodynamic effects of adrenomedullin in Wistar rats: a comparison with calcitonin gene-related peptide.

Authors:  Junsuke Kawai; Katsuyuki Ando; Tatsuo Shimosawa; Kiyonori Harii; Toshiro Fujita
Journal:  Hypertens Res       Date:  2002-05       Impact factor: 3.872

8.  Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.

Authors:  W Ma; J-G Chabot; K J Powell; K Jhamandas; I M Dickerson; R Quirion
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

Review 10.  Vascular actions of calcitonin gene-related peptide and adrenomedullin.

Authors:  Susan D Brain; Andrew D Grant
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

View more
  9 in total

1.  Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling.

Authors:  Sophie C Egea; Ian M Dickerson
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

2.  Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension.

Authors:  Scott C Supowit; Khurshed A Katki; Travis W Hein; Prakash Gupta; Lih Kuo; Ian M Dickerson; Donald J Dipette
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

Review 3.  Role of CGRP-receptor component protein (RCP) in CLR/RAMP function.

Authors:  Ian M Dickerson
Journal:  Curr Protein Pept Sci       Date:  2013-08       Impact factor: 3.272

4.  Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis.

Authors:  Claudia Sardi; Laura Zambusi; Annamaria Finardi; Francesca Ruffini; Adviye A Tolun; Ian M Dickerson; Marco Righi; Daniele Zacchetti; Fabio Grohovaz; Luciano Provini; Roberto Furlan; Stefano Morara
Journal:  J Neuroimmunol       Date:  2014-03-19       Impact factor: 3.478

Review 5.  Calcitonin gene-related peptide: physiology and pathophysiology.

Authors:  F A Russell; R King; S-J Smillie; X Kodji; S D Brain
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

6.  Nicousamide normalizes renovascular hypertension in two-kidney one-clip hypertensive rats.

Authors:  Sen Zhang; Hongyan Li; Yan Li; Furong Zhang; Yue Liu; Xiaoguang Chen
Journal:  Biomed Rep       Date:  2012-10-22

7.  A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.

Authors:  Aisah A Aubdool; Pratish Thakore; Fulye Argunhan; Sarah-Jane Smillie; Moritz Schnelle; Salil Srivastava; Khadija M Alawi; Elena Wilde; Jennifer Mitchell; Keith Farrell-Dillon; Daniel A Richards; Giuseppe Maltese; Richard C Siow; Manasi Nandi; James E Clark; Ajay M Shah; Anette Sams; Susan D Brain
Journal:  Circulation       Date:  2017-04-26       Impact factor: 29.690

Review 8.  The potential role of TRPV1 in pulmonary hypertension: Angel or demon?

Authors:  Xin Zhang; Lifang Ye; Yu Huang; Xueyan Ding; Lihong Wang
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

9.  Calcitonin gene-related peptide: An intra-articular therapeutic target for TMJ disorders.

Authors:  Sabine M Brouxhon; M Kerry O'Banion; Ian M Dickerson; Stephanos Kyrkanides
Journal:  Clin Exp Dent Res       Date:  2022-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.